Skip to main content

Table 3 Association of PsAID-12 with other PROMs and indices of disease activity (spearman correlation coefficient)

From: Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease

Variables

PsAID-12

HAQ-DI

0.657***

SF-36 (Physical Component)

−0.756***

SF-36 (Mental Component)

−0.701***

MDA

−0.667***

DLQI

0.474***

PASI

0.288**

DAS 28

0.443***

ASDAS ESR

0.671***

ASDAS CRP

0.645***

BASDAI

0.683***

PGA skin

0.463***

PGA joint

0.748***

VAS global patient

0.684***

VAS patient pain

0.734***

Counting painful joints

0.300***

Counting swollen joints

0.319***

DAPSA

0,610***

  1. PsAID Psoriatic Arthritis Impact of Disease, HAQ-DI Health Assessment Questionnaire Disability Index, SF-36 Medical Outcomes Study 36 - Item Short - Form Health Survey, MDA minimal disease activity, DLQI Dermatology life Quality Index, PASI Psoriasis Area Severity Index, DAS 28 Disease Activity Score 28, ASDAS Ankylosing Spondylitis Disease Activity Score, CRP C Reactive Protein, ESR Erythrocyte Sedimentation Rate, BASDAI Bath Ankylosing Spondylitis Activity Index, PGA Patient Global Assessment, VAS Visual Analog Scale, SPARCC Spondyloarthritis Research Consortium of Canada Enthesitis Index, DAPSA Disease Activity in Psoriatic Arthritis index
  2. * p < 0.05; ** p < 0.01; *** p < 0.001
Back to article page

Advances in Rheumatology

ISSN: 2523-3106